#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary ataxia Thrombotic thrombocytopenic purpura Cytomegalovirus infection Cluster headache Neuronal ceroid lipofuscinosis Nasopharyngeal cancer Emphysema Obliterative bronchiolitis Fragile X syndrome Ischaemic stroke Autoinflammation with infantile enterocolitis Cerebral arteriovenous malformation haemorrhagic Acute graft versus host disease in liver Anti-myelin-associated glycoprotein associated polyneuropathy Mixed-type liposarcoma More trials…

    Learn about Rare Diseases

    Synovial sarcoma metastatic – Trials in Disease Waldenstrom’s macroglobulinaemia refractory – Diagnostics Retinoblastoma – Life with Disease Idiopathic pulmonary fibrosis – Diagnostics Glycogen storage disease type II Nodal marginal zone B-cell lymphoma – Diagnostics Mucopolysaccharidosis I – Treatment Rhabdomyosarcoma – Basic Information Breast angiosarcoma – Life with Disease Combined immunodeficiency – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Siltuximab GSKVX000000070965 Botensilimab C1 Esterase Inhibitor (Human) VG801-1 Chloroprocaine Hydrochloride Cpft Trifluoroacetate Triamcinolone Acetonide Aripiprazole SODIUM SULFIDE NONAHYDRATE Dabrafenib Mesylate Valine Brimonidine Autologous Pancreatic Islets Bulevirtide Perflutren Dirocaftor Teriparatide [11C]Az14193391 Azathioprine More therapies…

    Learn about Your Condition

    Cervix carcinoma stage III Peripheral artery restenosis Hyperparathyroidism secondary Lichen planopilaris Toxicity to various agents Type 2 diabetes mellitus Spinal pain Lip and/or oral cavity cancer Synovial sarcoma metastatic Pyoderma gangrenosum Measles Systemic infection Fibromyalgia Prinzmetal angina Chronic hepatitis B More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Clear cell renal cell carcinoma

  • Study on the Safety and Effects of [68Ga]Ga-DPI-4452 and [177Lu]Lu-DPI-4452 in Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ductal adenocarcinoma of pancreas
    • Clear cell renal cell carcinoma
    • Colorectal cancer
    Investigated Drugs:
    • 177Lu-Dpi-4452
    • 68Ga-Dpi-4452
    • Acetazolamide
    Belgium France

  • Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Relatlimab
    • Ipilimumab
    • N-(4-Fluorophenyl)-N-(4-((7-Methoxy-6-(Methylcarbamoyl)Quinolin-4- Yl)Oxy)Phenyl)Cyclopropane-1,1-Dicarboxamide
    Austria Belgium France Germany Italy Poland +1

  • REGN10597 Alone or with Cemiplimab in Adults with Advanced Solid Tumours, Melanoma, or Clear-Cell Renal-Cell Carcinoma

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Clear cell renal cell carcinoma
    • Neoplasm
    Investigated Drugs:
    • Cemiplimab
    France Germany Italy Spain

  • A study of pembrolizumab, belzutifan, and lenvatinib before main treatment in patients with localized kidney cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • Belzutifan
    • Lenvatinib
    • Pembrolizumab
    Spain

  • Study on Raludotatug Deruxtecan for Patients with Advanced or Metastatic Solid Tumors, Including Gynecological and Genitourinary Cancers

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Cervix carcinoma
    • Ovarian cancer
    Investigated Drugs:
    • Raludotatug Deruxtecan
    Belgium Denmark France Italy Spain

  • Study of Cabozantinib for Patients with Advanced Renal Cell Carcinoma Previously Treated with One Immunotherapy Drug

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Clear cell renal cell carcinoma
    Investigated Drugs:
    • Cabozantinib
    Italy
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!